New insights into the mechanisms of islet inflammation in type 2 diabetes

Diabetes

Volumn 64, Issue 4, 2015, Pages 1094-1096

  Marzban, Lucy ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CASPASE 8; FATTY ACID; GLUCOSE; HYDRALAZINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

BLOOD PRESSURE REGULATION; CYTOKINE PRODUCTION; GLUCAGON RELEASE; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PANCREAS ISLET;

ANGIOTENSIN II; ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; VASOCONSTRICTION;

EID: 84930001739     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1903     Document Type: Note

References (20)

1. Costes S, Langen R, Gurlo T, Matveyenko AV, Butler PC. β-Cell failure in type 2 diabetes: A case of asking too much of too few? Diabetes 2013;62: 327-335
2. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: Perspectives on the past, present, and future. Lancet 2014;383: 1068-1083
3. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1βeta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110: 851-860
4. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007;56: 2356-2370
5. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11: 98-107
6. Park YJ, Lee S, Kieffer TJ, et al. Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide. Diabetologia 2012;55: 1035-1047
7. Westwell-Roper CY, Chehroudi CA, Denroche HC, Courtade JA, Ehses JA, Verchere CB. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice. Diabetologia 2015; 58: 575-585
8. Westwell-Roper CY, Ehses JA, Verchere CB. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction. Diabetes 2014;63: 1698-1711
9. Park YJ, Woo M, Kieffer TJ, et al. The role of caspase-8 in amyloid-induced beta cell death in human and mouse islets. Diabetologia 2014;57: 765-775
10. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998;41: 1241-1248
11. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009;52: 1686-1688
12. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356: 1517-1526
13. Ehses JA, Lacraz G, Giroix MH, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 2009;106: 13998-14003
14. Sloan-Lancaster J, Abu-Raddad E, Polzer J, et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes. Diabetes Care 2013;36: 2239-2246
15. Maedler K, Sergeev P, Ehses JA, et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1βeta in human islets. Proc Natl Acad Sci USA 2004;101: 8138-8143
16. Böni-Schnetzler M, Boller S, Debray S, et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 2009;150: 5218-5229
17. Sauter NS, Thienel C, Plutino Y, et al. Angiotensin II induces interleukin-1b-mediated islet inflammation and β-cell dysfunction independently of vasoconstrictive effects. Diabetes 2015;64: 1273-1283
18. Maedler K, Schumann DM, Sauter N, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 2006;55: 2713-2722
19. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004;53: 989-997
20. Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006;55: 367-374